BioSpace News Archive

CellChorus Awarded $2.3 million SBIR Fast-Track Grant by the National Institute of General Medical Sciences

Up to $2.3 million in funding from NIH will be used to scale the company’s TIMING platform for use in any laboratory or facility to improve development and delivery of novel therapies

June 20, 2023
·
3 min read
StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) (“StageZero” or the “Company”), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions,

June 20, 2023
·
6 min read
Business

Nexcella Appoints Jeffrey H. Cooper, former Chief Financial Officer of BioMarin, to Board of Directors

Nexcella, Inc., announced that effective , Jeffrey H. Cooper, former Chief Financial Officer of BioMarin Pharmaceutical Inc., has been appointed to the Company’s Board of Directors.

June 20, 2023
·
5 min read
Business

Spinal Elements Announces Appointment of Susan Denman to the Board

Spinal Elements, a spine technology company, announced the appointment of Susan Denman to the Company’s Board of Directors.

June 20, 2023
·
3 min read
Biotech Beach

Aardvark Therapeutics Announces FDA Orphan Drug Designation Granted to ARD-101, a Novel Drug Candidate for Prader-Willi Syndrome

Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company, today reported receipt of an Orphan Drug Designation from the FDA for its lead program, ARD-101, an oral small molecule bitter taste receptor (TAS2R) agonist.

June 20, 2023
·
4 min read
Mindpeak And Proscia Partner To Improve Cancer Diagnosis With Integrated AI-Powered Pathology Workflows

Collaboration marks step forward in realizing the promise of precision medicine

June 20, 2023
·
4 min read
BioMidwest

Visura Technologies Presents TEECAD Real-World Clinical Data at ASE 2023

Visura Technologies, Inc. announced it will be attending the American Society of Echocardiography’s 34th Annual Scientific Sessions in Baltimore, MD June 23-26.

June 20, 2023
·
3 min read
Drug Development

Annovis Bio Receives Excellent Safety Rating and Positive Recommendation to Continue Phase III Trial of Buntanetap for Parkinson’s Disease Patients from the Independent Data and Safety Monitoring Board (DSMB)

Annovis Bio, Inc. (NYSE: ANVS), announces the positive safety review by the Data and Safety Monitoring Board (DSMB) for its phase III trial of buntanetap, a drug for early Parkinson’s Disease (PD) patients.

June 20, 2023
·
4 min read
Genetown

Leap Therapeutics Announces Reverse Stock Split - June 20, 2023

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced that it will effect a 10-for-1 reverse stock split of its issued and outstanding common stock, effective at 5PM ET on June 20, 2023.

June 20, 2023
·
6 min read
Job Trends

Lilly to present new research in the treatment of diabetes and obesity at the American Diabetes Association’s® 83rd Scientific Sessions

Eli Lilly and Company (NYSE: LLY) will present 40 abstracts across its diabetes and obesity portfolio and pipeline at the American Diabetes Association’s® (ADA) 83rd Scientific Sessions in San Diego from June 23 - 26.

June 20, 2023
·
13 min read